BioCentury
ARTICLE | Top Story

Novartis' NIBR taps Bradner to replace Fishman

September 25, 2015 12:10 AM UTC

Novartis AG (NYSE:NVS; SIX:NOVN) named James Bradner president of the Novartis Institutes for BioMedical Research (NIBR) and a member of Novartis' executive committee.

He replaces Mark Fishman, who will retire in March 2016 after 13 years with the company. ...